|
|
1120 South Freeway
Fort Worth, TX 76104
phone:(817) 727-4150
fax:
|
|
| Symbol |
Private |
| Founded |
2008 |
| Employees |
|
|
|
| www.zspharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Their compound, known as Zirconium Silicate (ZrSi), selectively removes life-threatening toxins in patients suffering from kidney and liver disease and related conditions. |
|
| Management |
| Alvaro F. Guillem, Ph.D. � President and CEO
Stephen R. Ash, M.D. � Chief Medical Officer |
| |
|
|
| |
|
| Keywords |
| kidney, liver,oral sorbent, renal |
|
|
|
| Description |
|
ZS Pharma, Inc. is a privately held specialty pharmaceutical company located in Ft. Worth, TX and focused on the development and commercialization of proprietary oral sorbent technology. Their compound, known as Zirconium Silicate (ZrSi), selectively removes life-threatening toxins in patients suffering from kidney and liver disease and related conditions. They have secured exclusive intellectual property and are pursuing multiple indications to address significant, poorly-met medical conditions (acute and chronic hyperkalemia, hyperammonemia, hyperphosphatemia). ZS Pharma have conducted compelling in vitro and in vivo studies and have hired a highly diverse, seasoned executive team. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members